pneumonia OpGen Unyvero IVD Platform Nabs Chinese Regulatory Approval The company's cartridge for pneumonia for the Unyvero system is under review and pending approval by Chinese regulators. BioMérieux's BioFire Pneumonia Panel Could Improve Care, Find Secondary Infection in COVID-19 Cases Premium A handful of recently published trials suggest that use of the pneumonia panel could lead to more targeted therapy delivered more quickly than standard methods. Curetis, Karolinska Institute Collaborate to Identify Bacterial Co-Infections in COVID-19 Patients The institute will use Curetis' Unyvero Hospitalized Pneumonia panel on high-risk patients admitted to the ICU for COVID-19 pneumonia. FDA Clears Curetis Lower Respiratory Tract Infections Panel The LRT BAL panel detects a wide spectrum of clinically relevant causative agents, such as atypical pathogens and antibiotic resistance markers. Streptococcus Pneumoniae Changes in Response to Vaccine Introduction, Global Genomic Survey Finds The Global Pneumococcal Sequencing consortium found that non-vaccine-type bacteria increased after the introduction of pneumococcal conjugate vaccines. Apr 11, 2019 Curetis 2018 Revenues Grow 17 Percent Feb 6, 2019 AstraZeneca Spinoff Entasis Inks Deal to Use BioFire Tests Feb 4, 2019 Curetis Partner Submits MDx System, Pneumonia Test for Chinese Regulatory Approval Jan 30, 2019 Curetis Receives Malaysia, Thailand Regulatory Approvals Dec 13, 2018 Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring Nov 13, 2018 BioMérieux Pneumonia Panels Get FDA 510(k) Clearance, CE Mark Oct 11, 2018 Curetis Extends Distribution Agreement With Beijing Clear Biotech in China May 17, 2018 Veracyte Launches Early-Access Program for Idiopathic Pulmonary Fibrosis Test Apr 19, 2018 BioMérieux Q1 Revenues Up 3 Percent Apr 4, 2018 Curetis Unyvero System, Lower Respiratory Tract Infection Cartridge Get FDA Clearance Feb 6, 2018 Curetis Gets Singapore Approval for Pneumonia Test Jul 31, 2017 IDbyDNA, ARUP Laboratories Partner to Develop, Commercialize NGS Infectious Disease Tests May 12, 2017 Metagenomic Analysis Tool Taxonomer IDs Multiple Pathogens From Clinical Samples May 11, 2017 With New Instrument and Assay Claims, BioMérieux Takes on Antibiotic Stewardship Premium Oct 26, 2016 Curetis Wraps Up US Clinical Trial for Lower Respiratory Infection Panel; Readies FDA Submission Premium Jun 15, 2016 FDA Clears Meridian Bioscience's Updated Mycoplasma Pneumoniae Test Mar 3, 2016 Curetis Validating Blood Culture Cartridge for CE-IVD Launch in Q2 Premium Jan 13, 2016 Cepheid, MedImmune, COMBACTE Ink Bacterial Dx Collaboration Aug 20, 2015 Comparative Sequencing Study Sheds Light on Mycoplasma Pneumoniae Evolution Apr 17, 2015 Curetis Second-gen Pneumonia Test Gets CE Mark, Set to Launch Later This Month Premium Load More Breaking News Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution Thermo Fisher, Oncocyte Ink Development, Comarketing Deal for Cancer IVDs Yourgene Health Enters Three-Year £5M Term Loan Facility The Scan And a Fourth? A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times. For Better Science Software A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports. Recommendation Explanations The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information. Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.